脆弱性和心脏代谢结果:叙述性审查
Saam Foroshani1, Kevin S Tang1, Nathan D Wong2
1Department of Medicine, University of California Irvine Medical Center, Orange, CA 92868, USA.
Journal of clinical medicine
|February 27, 2026
概括
虚弱显著影响心血管疾病 (CVD) 的结果,增加死亡率和不良事件的风险. 然而,干预措施可能会减缓或逆转脆弱性,改善患者的护理.
科学领域:
- 老年学是指老年学的学科.
- 心脏病学 心脏病学
- 内部医学 内部医学
背景情况:
- 虚弱是影响心血管疾病 (CVD) 结果的关键因素.
- 人口老龄化和心脏代谢多病症的增加凸显了需要了解脆弱性在心血管疾病中的作用.
- 脆弱性独立地预测了各种心血管疾病的不良结果.
研究的目的:
- 审查目前关于心血管疾病脆弱性的证据.
- 探索定义,评估,流行病学,以及脆弱性和心血管疾病之间的联系机制.
- 讨论心血管疾病管理中的虚弱的预后价值和干预措施.
主要方法:
- 这是一个叙事综述,综合了当代证据.
- 该审查涵盖了脆弱性定义,评估工具和流行病学数据.
- 讨论了机制性途径,结果,预后价值和干预措施.
主要成果:
- 虚弱性与增加的死亡率,主要不良心血管事件 (MACE),再住院和心血管疾病患者的生活质量下降有关.
- 像炎症,肉症和内皮功能障碍这样的共享机制连接了脆弱和心血管疾病.
- 虚弱的预后价值超过了传统的风险因素,尽管评估工具各不相同.
结论:
- 脆弱性是心血管疾病结果的关键决定因素,需要量身定制的风险分层和患者护理.
- 了解双向关系和共享机制对于管理CVD至关重要.
- 脆弱不是不可改变的;像调节这样的干预措施可以改善心血管疾病患者的脆弱或脆弱前状态.
相关概念视频
Pharmacodynamics in Geriatric Patients: Effects of Age
284
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
284
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
273
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
273
Heart Failure II: Pathophysiology
1.1K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.1K
Heart Failure III: Clinical Manifestations
719
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
719
Heart Failure I: Introduction
1.0K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.0K
Cardiomyopathy VI: Nursing Management
408
Assessment: Nursing management of patients with cardiomyopathy begins with a thorough assessment of the patient's history, including a family history of cardiomyopathy or sudden cardiac death, personal history of heart disease, hypertension, diabetes, and any alcohol consumption or drug use.During the physical examination, assess vital signs, look for signs of heart failure (such as edema, jugular venous distention, and cyanosis), auscultate for abnormal heart sounds (like murmurs and gallops),...
408


